Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, Levi M, Samama CM, Thachil J, Giannis D, Douketis JD; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Spyropoulos AC, et al. Among authors: giannis d. J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929. J Thromb Haemost. 2020. PMID: 32459046 Free PMC article. No abstract available.
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
Cohen SL, Gianos E, Barish MA, Chatterjee S, Kohn N, Lesser M, Giannis D, Coppa K, Hirsch JS, McGinn TG, Goldin ME, Spyropoulos AC; Northwell Health COVID-19 Research Consortium. Cohen SL, et al. Among authors: giannis d. Thromb Haemost. 2021 Aug;121(8):1043-1053. doi: 10.1055/a-1366-9656. Epub 2022 Mar 11. Thromb Haemost. 2021. PMID: 33472255 Free PMC article.
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.
Spyropoulos AC, Cohen SL, Gianos E, Kohn N, Giannis D, Chatterjee S, Goldin M, Lesser M, Coppa K, Hirsch JS, McGinn T, Barish MA; COVID‐19 Consortium Group. Spyropoulos AC, et al. Among authors: giannis d. Res Pract Thromb Haemost. 2021 Feb 24;5(2):296-300. doi: 10.1002/rth2.12486. eCollection 2021 Feb. Res Pract Thromb Haemost. 2021. PMID: 33733028 Free PMC article.
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Sharifova G, Cohen M, Lund JM, Mignatti A, Gianos E, Tafur A, Lewis PA, Cohoon K, Kittelson JM, Lesser ML, Sison CP, Rahman H, Ochani K, Hiatt WR, Dale RA, Anderson VE, Bonaca M, Halperin JL, Weitz JI, Spyropoulos AC. Goldin M, et al. Among authors: giannis d. Thromb Haemost. 2021 Dec;121(12):1684-1695. doi: 10.1055/a-1475-2351. Epub 2021 May 28. Thromb Haemost. 2021. PMID: 33823560
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder GS, Schnitzer A, Goldberg B, McGinn T, Davidson KW, Barish MA, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos AC. Giannis D, et al. Blood. 2021 May 20;137(20):2838-2847. doi: 10.1182/blood.2020010529. Blood. 2021. PMID: 33824972 Free PMC article.
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
Goldin M, Lin SK, Kohn N, Qiu M, Cohen SL, Barish MA, Gianos E, Diaz A, Richardson S, Giannis D, Chatterjee S, Coppa K, Hirsch JS, Ngu S, Firoozan S, McGinn T, Spyropoulos AC. Goldin M, et al. Among authors: giannis d. J Thromb Thrombolysis. 2021 Nov;52(4):1032-1035. doi: 10.1007/s11239-021-02504-5. Epub 2021 Jun 19. J Thromb Thrombolysis. 2021. PMID: 34146235 Free PMC article.
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI; HEP-COVID Investigators. Spyropoulos AC, et al. Among authors: giannis d. JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203. JAMA Intern Med. 2021. PMID: 34617959 Free PMC article. Clinical Trial.
61 results